Klinikum Stuttgart

Running trials

• Active, not recruiting

  Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

  NCT05689671· Phase 4· Source

• Recruiting

  Glioblastoma Radiotherapy Using IMRT or Proton Beams

  NCT04752280· Source

• Recruiting

  FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

  NCT04625907· Phase 1/2· Source

• Active, not recruiting

  Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

  NCT04230759· Phase 2· Source

• Recruiting

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  NCT04221035· Phase 3· Source

• Active, not recruiting

  Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics

  NCT03897127· Phase 3· Source

• Active, not recruiting

  Automatic PredICtion of Edema After Stroke

  NCT04057690· Source

• Recruiting

  BAROSTIM THERAPY™ In Resistant Hypertension

  NCT02880631· Source

• Active, not recruiting

  Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

  NCT02685605· Phase 3· Source

• Recruiting

  International HIT-MED Registry (I-HIT-MED)

  NCT02417324· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• Glioblastoma1 recruiting
• High blood pressure1 recruiting
• Neuroblastoma1 recruiting
• Sarcoma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)

  NCT02013648· Phase 3· Source